Literature DB >> 220660

Studies of hypoparathyroidism and pseudohypoparathyroidism.

I G Lewin, S E Papapoulos, S Tomlinson, G N Hendy, J L O'Riordan.   

Abstract

Twenty eight hypocalcaemic patients were studied, 14 with primary hypoparathyroidism, nine with pseudohypoparathyroidism and two with hypo-hyperparathyroidism, to characterized the essential features of these disorders. Like tetany, which was present in 12 of the patients, epilepsy was a common symptom, occurring in 13, seven of whom had received anticonvulsants for two to eight years before hypocalcaemia was detected. Differentiation between primary and pseudohypoparathyroidism could not be made with certainty on clinical grounds but confident distinction could be made by measurement of endogenous parathyroid hormone concentrations and by testing for renal resistance to exogenous parathyroid hormone. This was achieved by measurement of the plasma and, in some patients, the urinary cyclic AMP response to an intravenous injection of highly purified bovine parathyroid hormone. These investigations were also valuable in the assessment of the other three hypocalcaemic patients in whom a diagnosis of parathyroid dysfunction would otherwise have been made. In 10 of the patients synthetic 1 alpha-hydroxylated forms of vitamin D were used to establish and maintain normocalcaemia, though their use required careful monitoring.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 220660

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  6 in total

1.  Pseudohypoparathyroidism with normal phosphaturic response to exogenous parathyroid hormone administration.

Authors:  S O'Neill; F Walker; W F O'Dwyer
Journal:  Ir J Med Sci       Date:  1981-07       Impact factor: 1.568

2.  Facial dysmorphia, parathyroid and thymic dysfunction in the father of a newborn with the DiGeorge complex.

Authors:  P D Maaswinkel-Mooij; S E Papapoulos; E J Gerritsen; A H Mudde; J J Van de Kamp
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

3.  Frontal lobe calcification in hypoparathyroid states.

Authors:  R A Bloom; D Rubinger; H Pogrund
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

4.  Hypercalcaemia in alphacalcidol therapy.

Authors:  C R Paterson
Journal:  Postgrad Med J       Date:  1981-07       Impact factor: 2.401

5.  Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygous PTH1R mutation.

Authors:  R Guerreiro; J Brás; S Batista; P Pires; M H Ribeiro; M R Almeida; C Oliveira; J Hardy; I Santana
Journal:  Genes Brain Behav       Date:  2016-08-24       Impact factor: 3.449

6.  Familial pseudohypoparathyroidism presenting in adult life.

Authors:  D V Hamilton
Journal:  J R Soc Med       Date:  1980-10       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.